Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any inherited bleeding disorder, platelet-type in which the cause of the disease is a mutation in the GP6 gene.
Features include always present findings: Prolonged bleeding time, Impaired collagen-induced platelet aggregation, and Ecchymosis. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 4 | Impaired ristocetin-induced platelet aggregation, Prolonged bleeding time, Impaired collagen-induced platelet aggregation |
GP6 encodes glycoprotein VI platelet (339 aa). Collagen receptor involved in collagen-induced platelet adhesion and activation. Plays a key role in platelet procoagulant activity and subsequent thrombin and fibrin formation.
Platelet-type bleeding disorder 11 is caused by mutations in the GP6 gene on chromosome 19.
GP6 is classified as a druggable target (Cell Surface and Kinase categories) with score 26.1.
Genetic testing for GP6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for platelet-type bleeding disorder 11 has been reported in the published literature.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for platelet-type bleeding disorder 11.
5 publications have been identified in PubMed for platelet-type bleeding disorder 11. Research spans Basic Science / Preclinical (40%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).
Othman M (2025). [PMID: 40328428](https://pubmed.ncbi.nlm.nih.gov/40328428/). *Journal of thrombosis and haemostasis : JTH*. [Review / Meta-Analysis]
do Nascimento MF (2025). [PMID: 39953195](https://pubmed.ncbi.nlm.nih.gov/39953195/). *Scientific reports*. [Diagnostic / Biomarker]
Broojerdi MH (2025). [PMID: 40651280](https://pubmed.ncbi.nlm.nih.gov/40651280/). *Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis*. [Basic Science / Preclinical]
Montague SJ (2024). [PMID: 38492852](https://pubmed.ncbi.nlm.nih.gov/38492852/). *Journal of thrombosis and haemostasis : JTH*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 17, 2026, 10:23 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center